naturally occurring glp 1 agonists GLP-1 Genetics: How Genes Affect Appetite, Semaglutide, and Tirzepatide Response GLP-1 Agonists for Weight Loss:

This continuous monitoring and analysis of emerging data are crucial for informing healthcare providers and patients about the potential risks and benefits of GLP-1 medications

Am J Med (2010) 123:468

To successfully employ an all-comers strategy moving forward, manufacturers need to ensure products have strong clinical and/or non-clinical differentiation, a robust data package that addresses a range of patient types and comorbidities, and well-funded physician and patient facing marketing campaigns

PMID 20833867

Reduce glucagon secretion from pancreatic alpha cells and hepatic glucose output

"Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss"